Cita APA (7a ed.)
Shoemaker, K., Soboleva, K., Branche, A., Shankaran, S., Theodore, D. A., Bari, M., . . . Sobieszczyk, M. E. (2024). Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study. Vaccines. https://doi.org/10.3390/vaccines12080883
Cita Chicago Style (17a ed.)
Shoemaker, Kathryn, et al. "Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 NCoV-19): 2-Year Follow-Up from a Phase 3 Study." Vaccines 2024. https://doi.org/10.3390/vaccines12080883.
Cita MLA (9a ed.)
Shoemaker, Kathryn, et al. "Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 NCoV-19): 2-Year Follow-Up from a Phase 3 Study." Vaccines, 2024, https://doi.org/10.3390/vaccines12080883.
Precaución: Estas citas no son 100% exactas.